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Catechin-incorporated dental copolymers inhibit 
growth of Streptococcus mutans
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Objective: To test the inhibitory growth activity of green tea catechin incorporated into dental resins compared to resins containing the broad-spectrum antimicrobial compound 
chlorhexidine against Streptococcus mutans in vitro. Material and Methods: The minimum 
inhibitory concentrations (MICs) of epigallocatechin-gallate (EGCg) and chlorhexidine (CHX) 
were determined according to the microdilution method. Resin discs (5 mm x 3 mm) were 
prepared from Bis-GMA/TEGDMA (R1) and Bis-GMA/CH3	
		
	
containing: a) no drug, b) EGCg, c) CHX. Two concentrations of each drug (0.5x MIC and 
1x MIC) were incorporated into the resin discs. Samples were individually immersed in a 
bacterial culture and incubated for 24 h at 37°C under constant agitation. Cell viability was 
assessed by counting the number of colonies on replica agar plates. Statistical analysis 
was performed using one-way ANOVA, Tukey and Student t-tests (α			
	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to resins containing CHX at 0.5x MIC and 1x MIC, and EGCg at 1x MIC when compared 
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inhibition than in R2. Conclusions: Both EGCg and CHX retained their antibacterial activity 
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	6#		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reduced S. mutans survival at a level similar to CHX. The data generated from this study will 
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#;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the lifespan of resin-based restorations.
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INTRODUCTION
Dental caries is a multifactorial and transmissible 
disease that originates mainly from the interplay of 
	@>		6*	>	#	#9	 +	
When organic acids are produced by the dental 
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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enamel and cementum. As the acid diffuses into 
		>	 	9	'#		#'F
carbonate rich acid soluble minerals, and begins 
to dissolve it7. When this process progresses long 
enough and reaches the dentin, the end result is 
tooth cavitation. The most common aetiological 
agents involved in this disease are Streptococcus 
mutans, followed by Streptococcus sobrinus, 
Lactobacillus, and Actinomyces12. Consequently, 
caries prevention is based on the control of at least 
one of the mentioned causing factors.
The broad-spectrum antibacterial chlorhexidine 
(CHX) is a very commonly used agent for the 
prevention or control of oral diseases. Studies have 
demonstrated that CHX is capable of arresting 
caries when applied to dentin3. However, CHX has 
some disadvantages, such as bacterial resistance, 
;	+'9		23,28 and toxicity 
to host tissues, motivating the investigation of 
alternatives2,21,24,31,32. Natural products, especially 
food extracts, have been shown to be good 
anticariogenic alternatives to synthetic chemicals8. 
The green tea polyphenol, epigallocatechin-gallate 
(EGCg) was found to inhibit acid production from 
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dental plaque bacteria, while showing antimicrobial 
activity against S. mutans14,30,34. Moreover, EGCg 
was shown to inhibit the matrix metalloproteinase 
activities present in the dentin (MMP-2 and MMP-9) 
and associated with caries progression10.
Many properties of restorative dental composites 
have been improved in the past decades, including 
the mechanical properties, masticatory and abrasive 
wear resistance, esthetics, and bonding to the 
enamel and dentin. Bis-GMA (bisphenol glycidyl 
dimethacrylate) is still today the most commonly 
used monomer in composite resin formulations. 
It has very high viscosity, thus dilution with low 
viscosity alkoxyalkyl dimethacrylate esters, such 
as TEGDMA (triethyleneglycol dimethacrylate) 
	 L#	 	 *	 #L	 '	 #	 #	
handling characteristics5. Dilution with such a 
monomer, however, increases polymerization 
shrinkage and water sorption19. Thus, research 
has also been directed towards developing more 
hydrophobic and stable hydroxyl-free monomers with 
lower viscosities, such as CH3bis-GMA (propoxylated 
bis-GMA) as a replacement for TEGDMA in resin 
formulations in order to reduce resin water sorption 
and polymerization shrinkage18.
It is therefore proposed that at this stage, 
advances of restoratives should happen towards the 
development of materials with bio-active functions, 
such as antibacterial activity to provide therapeutic 
effects16. It could be assumed that the long-term 
durability of resin-dentin bonds and restorations 
9	*'	+	###	9*#	
polymeric materials, capable of releasing bioactive 
compounds. The aim of this study was to test the 
antimicrobial activity of EGCg when compared to 
CHX, against the cariogenic organism S. mutans after 
being released by experimental dental copolymers. 
The null hypothesis to be tested is that different 
comonomers, incorporated drugs (CHX or EGCg) or 
drug ratios will not affect the growth of S. mutans.
MATERIAL AND METHODS
Bacterial strain, growth condition, and 
chemicals
The S. mutans UA159 strain isolated from a child 
with active caries was used in this study1. S. mutans 
was cultivated in Brain Heart Infusion (BHI) broth 
at 37°C in air with 5% CO2. BHI broth agar plates 
were prepared using 1.5% (w/v) agar. Bis-GMA, 
TEGDMA, the photosensitizer camphorquinone (CQ), 
reducing agent 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), CHX diacetate salt hydrate (Sigma-
Aldrich, St. Louis, MO, USA) and EGCg (Cayman 
Chemical Group, MI, USA) were all used as received. 
The Bis-GMA analog, CH3Bis-GMA (2,2-bis[4-(2-
methacryloxyprop-1-oxy)phenyl]propane) was 
9^#>	6'#>	#	#	#			
reported methods (Figures 1a to 1e)18. Briefly, 
bisphenol A was treated with propyleneoxide in 
the presence of NaOH and tetrahydrofuran (THF). 
The reaction product was isolated and then treated 
with 3 mols of methacryloyl chloride per mol of 
product, together with triethylamine in THF solvent 
to obtain CH3Bis-GMA. The synthesized monomer 
was dissolved in deuterochloroform at 5% (w/v) and 
characterized by proton nuclear magnetic resonance 
(1H NMR; Varian Unity 400, 400 MHz) and carbon 
nuclear magnetic resonance (13C NMR; General 
Electric GN500, 125MHz) at 25 ºC, providing spectra 
that were consistent with the expected product 
(Figure 1b).
Minimum inhibitory concentration (MIC)
Overnight cultures of S. mutans UA159 were 
diluted (1:20) into fresh BHI medium supplemented 
with different concentrations of drugs (CHX: 1, 2, 5, 
?>	?>		{F|}	!"	?>	>	>	?	~F
mL) and incubated at 37°C for 24 h. The cells were 
sonicated, serially diluted and, spot-plated onto BHI 
agar plates. Cell viability was assessed by counting 
colony forming units (CFUs). The minimum inhibitory 
concentration (MIC) test was performed according 
to the broth microdilution method using BHI broth 
as previously described29. Briefly, 105 CFU/ml 
of bacterial cells were added to a 96-well plate 
containing BHI medium supplemented with twofold 
serial dilutions of EGCg or CHX. Bacterial growth 
after 24 h was spectrophotometrically measured 
by using an ELISA microtiter plate reader (model 
Figure 1- Molecular structure of Bis-GMA (a), CH3Bis-
GMA (b), TEGDMA (c), CHX (d), and EGCg (e)
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3550; Bio-Rad Laboratories, Richmond, CA) at an 
absorbance of 490 nm (OD490). Relative bacteria 
density percentages were calculated by using the 
following equation: (OD490 of culture in the presence 
of each concentration of drug)/(OD490 of culture in the 
absence of drug) ×100. The MIC was determined as 
the lowest product concentration needed to ensure 
that the culture did not grow to over 10% of the 
relative bacterial cell density.
Formulation of comonomers and specimen 
preparation
The following two experimental resin formulations 
were prepared for this study: R1) Bis-GMA at 70 
mol% combined with TEGDMA at 30 mol%, or 
R2) Bis-GMA at 70 mol% combined with CH3Bis-
GMA at 30 mol%. Except for the control groups 
(no drugs added), each formulation was randomly 
mixed with either CHX or EGCg at 0.5x MIC or 
1x MIC corresponding to drug concentrations in 
weight percentage, comprising a total of 10 groups 

	"	&	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#	+	;*	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polymerization by the addition of CQ and DMAEMA 
(0.2 w/w% each). Specimens were fabricated inside 
a cylindrical acrylic matrix with internal dimensions 
of 5 mm diameter x 3 mm height. Unpolymerized 
material was sandwiched between two polyester 
strips over a glass-mixing tablet. Polymerization 
was done on both sides by a visible light curing unit 
(Demi LED, Kerr Co., WI, USA) for 40 s delivering 
uninterrupted 540 mW/cm2>	;'#	*9		#	
(Model 100, Demetron Research Co., CT, USA). 
Additional specimens were fabricated and the 24 h 
release rates of the drug loaded samples were tested 
spectrophotometrically as previously described22.
Bacterial viability assay
Overnight cultures of S. mutans UA159 were 
diluted (1:20) into 1.0 ml of fresh BHI broth followed 
by the addition of one resin sample per test tube. 
The reaction mixtures were incubated at 37°C for 24 
h under constant agitation. The next day, the cells 
&	#>	#	L	+		~	+			
tube were plated on BHI agar for CFU determination. 
The colonies were counted after 48 h of incubation. 
The percentage of cell survival corresponded to the 
number of viable cells after treatment divided by the 
total number of viable cells in the untreated sample.
Statistical analyses
The data were shown to have normal distribution 
and equal variances (Kolmogorov-Smirnof test). 
The student t-test was applied to the bacterial cell 
viability data comparing each tested group with its 
respective control, and all R1 and R2 counterparts 
(same drug and drug ratio). One-way ANOVA followed 
by Tukey test was used for each resin to compare 
the bacterial cell viability among groups containing 
#++	#	#			;	+	'	
was set at 0.05. Collected data were compiled and 
examined for relevance with the SPSS version 8.0 
(SPSS Inc., Chicago, IL) statistical program.
RESULTS
The MICs of CHX and EGCg obtained using S. 
mutans UA159 strain were 2 μg/mL and 700 μg/
mL, respectively. The 24 h drug release rates for R1 
	"$%	
<	="?	{F2	#	?<	="?	
μg/cm2	#	!"	
<	="	{F2 and 1x 
="?	 {F2); and for R2 are: CHX (0.5x 
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	{F2) and 
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μg/cm2). The cell viability for drug-containing Bis-
GMA/TEGDMA (R1) and Bis-GMA/CH3Bis-GMA (R2) 
is presented in Table 1. The results demonstrated 
that both CHX and EGCg drugs retained their 
antimicrobial activity when integrated as part of R1 
and R2 restorative materials. In each resin tested, 
	&		'	#++		*	&	
inhibition between the treatment groups (CHX 0.5x 
MIC, CHX 1x MIC, and EGCg 1x MIC), with the 
<6	+	!"		<	="		#	'9	
higher survival values (p<0.05). Moreover, when 
comparing R1 and R2 incorporated with the same 
#	#	#	>		'	#++	&	
found within the groups except for EGCg at 0.5x MIC 
	?		#		'9	 &	6	+	
Groups Control LM
 LM EGCg EGCg
0.5X MIC (s.d.) 1X MIC (s.d.) 0.5X MIC (s.d.) 1X MIC (s.d.)
Bis-GMA/
TEGDMA
(R1)
100Aa 0.07 (0.09)Bb 0.0Bb 29.05 (12.16)Cc 2.41 (0.87)Be
Bis-GMA/CH3Bis-
GMA
(R2)
100Aa 0.30 (0.16)Bb 0.01 (0.017)Bb 52.38 (18.33)Cd 6.58 (6.22)Be
Table 1- Effect of drug-incorporated resins on S. mutans survival percentage
*ANOVA and Tukey’s test; α	
				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
each line. Same lower case letters indicate no statistical difference within each column
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cell survival rate when compared to R2. The initially 
proposed null hypothesis is therefore rejected.
DISCUSSION
The controlled release of drugs or bioactive 
agents from polymers by Fickian diffusion, which 
is the spreading of solutes from regions of highest 
to regions of lower concentrations caused by the 
concentration gradient, has been the subject of 
research for many years27. In dentistry, CHX-
containing resins have been successfully tested in 
terms of drug release and antibacterial activity. Most 
of these studies, however, use the agar plate method, 
where test samples are applied onto microorganisms 
inoculated at the surface of an agar plate. After 
appropriate incubation, the appearance and diameter 
of zones of growth inhibition around the test product 
indicate antimicrobial activity6,15,17. In this study, 
the drug-containing resins were immersed into a 
bacterial suspension of the cariogenic organism 
S. mutans, which better mimics the physiological 
conditions in vivo. Moreover, these conditions 
allowed the resin samples to absorb water, swell, 
and have drugs diffused toward the surrounding 
solution from all surfaces. We demonstrated that 
polymerized R1 and R2 resins can effectively release 
incorporated CHX and EGCg, and that both drugs 
retain their antimicrobial activity upon incorporation 
into comonomers.
Drug release from resins is a process affected 
by many factors including, monomer type, degree 
of conversion, crosslinking density, drug type and 
concentration, and extracting media15,26. Therefore, 
the fact that R1 and R2 resins containing EGCg at 
0.5x MIC is less effective at inhibiting S. mutans 
growth compared to the EGCg at 1x MIC is in part 
explained by the lower amount of drug diffusing 
through the polymer chains into the extracting 
nutrient-rich BHI medium. Although statistically 
'	 9	 +	 !"	 	 <	 =">	 &	 	
survival rates were generally observed in response 
to R1 treatment groups compared to the R2 
counterparts. The CH3Bis-GMA analog exhibits 
higher hydrophobicity compared to Bis-GMA due to 
the absence of hydrogen bonding in the system as 
a result of the –OH substitution for the –CH3 group. 
Conversely, TEGDMA is a very hydrophilic monomer 
due to the presence of linear ether linkages25 (Figure 
?>	 ?*>	 ?	 	&	 6		 +'9	
into the R1 matrix leading to larger expansion of 
voids between the polymer chains, more elutable 
species including the incorporated drugs were likely 
extracted from these samples leading to higher 
bacterial growth inhibition. The fact that the more 
hydrophobic resin (CH3Bis-GMA-based) released less 
amounts of drugs in the given time range of 24 h, 
may suggest extended release in the long term21. 
Long term release studies should be carried out in 
order to verify this premise.
The MIC values for CHX and EGCg against 
S. mutans obtained in this study were within reference 
ranges; 0.25 – 4.0 μg/mL for CHX9,20 and 31.25 – 
625 μg/mL for EGCg34, depending on the bacterial 
strain and culture medium. After 24 h of incubation 
in the presence of drug-incorporated monomers 
(at sub-MIC and MIC), we demonstrated that both 
drugs were released from the test comonomers and 
+'9	*#	*	&}	"$%	*		
most effective. CHX is a bisguanide cationic broad-
spectrum antimicrobial compound, active against 
Gram-positive and Gram-negative bacteria. CHX 
electrostatically binds to the negatively charged 
bacterial surface and then forms pores or disrupts 
the membrane. At low concentrations, CHX has a 
bacteriostatic effect causing low molecular weight 
substances to leak out without damaging the cell 
irreversibly, while at high concentrations, CHX causes 
precipitation of cytoplasm exerting a bactericidal 
effect4,13.
					+	+'	#	#	+	
on the antibacterial mode of action of catechins. It 
is, however, recognized that these compounds have 
*#	+'	+		6>	&		&	
by the decrease in antibacterial activity of tea in the 
presence of serum33. The fact that slightly higher MIC 
values of EGCg were obtained in this work compared 
to other studies also suggest that proteins present in 
the nutrient-rich BHI medium may bind to green tea 
catechins reducing their antimicrobial activities. This 
might also explain the lower growth inhibition values 
of EGCg in comparison to CHX, despite the higher 
EGCg release results. Nevertheless, one could expect 
that the interactions of EGCg with proteins, causing 
'	#	+		9	>	9	
also account for the malfunction of certain bacterial 
enzymes. Interestingly, a study by Xu, et al.34 
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formation of S. mutans which could be attributed 
to the interactions of EGCg with glucosyltransferase 
enzymes, thus disrupting the formation and integrity 
+			*'		9>	%>		35 (2012) 
also demonstrated that EGCg suppresses the gtfB, 
gtfC, gtfD genes associated with extracellular 
polysaccharide formation of S. mutans. The potential 
anticariogenic activity of EGCg in clinical service 
clearly requires more research, since EGCg has been 
shown to interact with salivary proteins. Hara, et al.11 
(2012) demonstrated that EGCg inhibited the activity 
of alpha-amylase by non-competitive inhibition, 
indicating that EGCg is effective at inhibiting the 
formation of fermentable carbohydrates involved in 
caries formation.
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CONCLUSION
Both EGCg and CHX retain their antibacterial 
activity when incorporated into the resin matrix. 
Although less effective at the sub-MIC level, EGCg 
	?	#			'9	##		;;	
of the cariogenic organism S. mutans, suggesting 
a novel alternative to synthetic chemicals. The 
evident antibacterial activity of EGCg suggest novel 
approaches in the development of dental restorative 
materials to help control dental caries, the most 
common infectious disease affecting humans.
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